Release of arachidonic acid by 2-arachidonoyl glycerol and HU210 in PC12 cells; roles of Src, phospholipase C and cytosolic phospholipase A2α

European Journal of Pharmacology

Volumn 590, Issue 1-3, 2008, Pages 1-11

  Nabemoto, Maiko ^a   Mashimo, Masato ^a   Someya, Akiyoshi ^a   Nakamura, Hiroyuki ^a   Hirabayashi, Tetsuya ^a   Fujino, Hiromichi ^a   Kaneko, Masayuki ^b   Okuma, Yasunobu ^b   Saito, Takeshi ^c   Yamaguchi, Naoto ^a   Murayama, Toshihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA INSTITUTE OF SCIENCE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cannabinoid receptor; Cytosolic phospholipase A2; Phospholipase C; Protein kinase C; Rat PC12 cell; Src

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 BROMOPHENACYL BROMIDE; ARACHIDONIC ACID; CALCIMYCIN; CALCIUM; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CYCLIC AMP; DEXANABINOL; GREEN FLUORESCENT PROTEIN; HERBIMYCIN; MEPACRINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2ALPHA; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RIMONABANT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CYCLIC AMP; CYTOSOL; GLYCERIDES; GROUP IV PHOSPHOLIPASES A2; MICE; MICE, INBRED ICR; PC12 CELLS; PHOSPHORYLATION; PIPERIDINES; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-FYN; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TETRAHYDROCANNABINOL; TYPE C PHOSPHOLIPASES;

EID: 48049093695     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.064     Document Type: Article

References (58)

1. 2α level in rat PC12 cells. Neurosci. Lett. 365 (2004) 218-222
2. Anggadiredja K., Nakamichi M., Hiranita T., Tanaka H., Shoyama Y., Watanabe S., and Yamamoto T. Endocannabinoid system modulates relapse to methanphetamine seeking: possible mediation by the arachidonic acid vascade. Neuropsychopharmacology 29 (2004) 1470-1478
3. Ates M., Hamza M., Seidel K., Kotalla C.E., Ledent C., and Gühring H. Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test. Eur. J. Neurosci. 17 (2003) 597-604
4. Bahr B.A., Karanian D.A., Makanji S.S., and Makriyannis A. Targeting the endocannabinoid system in treating brain disorders. Expert Opin. Investig. Drugs 15 (2006) 351-365
5. Bari M., Battista N., Fezza F., Finazzi-Agró A., and Maccarrone M. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. J. Biol. Chem. 280 (2005) 12212-12220
6. Bayatti N., Hermann H., Lutz B., and Behl C. Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system. Endocrinology 146 (2005) 1205-1213
7. Begg M., Pacher P., Bátkai S., Osei-Hyiaman D., Offertáler L., Mo F.M., Liu J., and Kunos G. Evidence for novel cannabinoid receptors. Pharmacol. Ther. 106 (2005) 133-145
8. Bisogno T., Katayama K., Melck D., Ueda N., De Petrocellis L., Yamamoto S., and Di Marzo V. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells. Eur. J. Biochem. 254 (1998) 634-642
9. Chan G.C.K., Hinds T.R., Impey S., and Storm D.R. Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol. J. Neurosci. 18 (1998) 5322-5332
10. Davis M.I., Ronesi J., and Lovinger D.M. A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells. J. Biol. Chem. 278 (2003) 48973-48980
11. Demuth D.G., and Molleman A. Cannabinoid signalling. Life Sci. 78 (2006) 549-563
12. +6,7 by cannabinoids in hippocampus. J. Biol. Chem. 276 (2001) 38289-38296
13. Derkinderen P., Valjent E., Toutant M., Corvol J.C., Enslen H., Ledent C., Trzaskos J., Caboche J., and Girault J.A. Regulation of extracellular signal-regulated kinase by cannabinoids in hyppocampus. J. Neurosci. 23 (2003) 2371-2382
14. Erlandsson N., Baumann B., Rössler O.G., Kaufmann K., Giehl K.M., Wirth T., and Thiel G. Lack of correlation between NF-κB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940. Biochem. Pharmacol. 64 (2002) 487-495
15. Esposito G., De Filippis D., Maiuri M.C., De Stefano D., Carnuccio R., and Iuvone T. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement. Neurosci. Lett. 399 (2006) 91-95
16. Facchinetti F., Giudice E.D., Furegato S., Passarotto M., and Leon A. Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide. Glia 41 (2003) 161-168
17. 2. J. Biol. Chem. 277 (2002) 2614-2619
18. Glass M., van Dellen A., Blakemore C., Hannan A.J., and Faull R.L. Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors. Neuroscience 123 (2004) 207-212
19. Guo J., and Ikeda S.R. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inward rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol. Pharmacol. 65 (2004) 665-674
20. Hájos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
21. 2 via a Gqα-dependent ERK-independent pathway. J. Biol. Chem. 276 (2001) 13491-13948
22. Hart S., Fischer O.M., and Ullrich A. Cannabinoids induced cancer cell proliferation via tumor necrosis factor α-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 64 (2004) 1943-1950
23. o/i coupled cannabinoid receptor mediate neurite outgrowth involves Rap regulation of Src and Stat3. J. Biol. Chem. 280 (2005) 33426-33434
24. 2. J. Biol. Chem. 274 (1999) 5163-5169
25. 1 receptor-mediated signal transduction. Br. J. Pharmacol. 142 (2004) 1209-1218
26. Hunter S.A., and Burstein S.H. Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis. Life Sci. 60 (1997) 1563-1573
27. Ishii I., and Chun J. Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors. NeuroReport 13 (2002) 593-596
28. Kasahara K., Nakayama Y., Ikeda K., Fukushima Y., Matsuda D., Horimoto S., and Yamaguchi N. Trafficking of Lyn through the Golgi caveolin involves the charged residues on αE and αI helices in the kinase domain. J. Cell Biol. 165 (2004) 641-652
29. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., and Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 21 (2006) 2991-3001
30. Kouznetsova M., Kelley B., Shen M., and Thayer S.A. Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture. Mol. Pharmacol. 61 (2002) 477-485
31. q/11 G proteins. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19144-19149
32. Lauckner J.E., Jensen J.B., Chen H.Y., Lu H.C., Hille B., and Mackie K. CPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc. Natl. Acad. Sci. U. S. A. 105 (2007) 2699-2704
33. 2. J. Biol. Chem. 272 (1997) 16709-16712
34. Lutz B. Molecular biology of cannabinoid receptors. Prostaglandins Leukot. Essent. Fat. Acids 66 (2002) 123-142
35. 1 receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem. Int. 40 (2002) 157-167
36. 2 by sulfhydryl reagents. Arch. Biochem. Biophys. 436 (2005) 145-153
37. 2α activity by d-erythro-sphingosine. Eur. J. Pharmacol. 484 (2004) 9-17
38. 2α directly and by PKC pathway. Biochem. Pharmacol. 71 (2006) 850-857
39. Nilsson O., Fowlwe C.J., and Jacobsson S.O.P. The cannabinoid agonist WIN 55,212-2 inhibits TNF-α-induced neutrophil transmigration across ECV304 cells. Eur. J. Pharmacol. 547 (2006) 165-173
40. Obara Y., Labudda K., Dillon T.J., and Stork P.J.S. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J. Cell Sci. 117 (2004) 6085-6094
41. 2+ influx in Purkinje cells. Neuron 32 (2001) 113-122
42. Onaivi E.S. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 54 (2006) 231-246
43. 2α, pyrrophenone. Biochem. J. 363 (2002) 727-735
44. 1 Cannabinoid receptor stimulation modulates transient receptor potential vanilloid receptor 1 activates in calcium influx and substance P release in cultured rat dorsal root ganglion cells. J. Pharmacol. Sci. 97 (2005) 377-385
45. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev., Neurosci. 4 (2003) 873-884
46. Rubovitch V., Gafni M., and Sarne Y. The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells. Mol. Brain Res. 101 (2002) 93-102
47. Ryberg E., Larsson N., Sjögren S., Hjorth S., Hermansson N.O., Leonova J., Elebring T., Nilsson K., Drmota T., and Greasley P.J. The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 152 (2007) 1092-1101
48. Sarker K.P., and Maruyama I. Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. Cell. Mol. Life Sci. 60 (2003) 1200-1208
49. Sarker K.P., Biswas K.K., Yamakuchi M., Lee K.Y., Hahiguchi T., Kracht M., Kitajima I., and Maruyama I. ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. J. Neurochem. 85 (2003) 50-61
50. 1 receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 134 (2001) 664-672
51. 2+ ionophores, but not to tumor necrosis factor-α. J. Pharmacol. Sci. 96 (2004) 324-332
52. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., and Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270 (1995) 3726-3731
53. 2α formation induced by anandamide and capsaicin in PC12 cells. Eur. J. Pharmacol. 450 (2002) 131-139
54. 2 receptors. Science 310 (2005) 329-332
55. Wartmann M., Campbell D., Subramanian A., Burstein S.H., and Davis R.J. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett. 359 (1995) 133-136
56. 2 phosphorylation and arachidonic acid release in primary murine astrocytes. J. Neurochem. 83 (2002) 259-270
57. 8-tetrahydrocannabinol. J. Neurochem. 88 (2004) 148-154
58. 1 receptors in models of diabetic neuropathy. J. Pharmacol. Exp. Ther. 323 (2007) 508-515